ASCO Genitourinary Cancers Symposium
M

ASCO GU 2022 Germline Mutations of Interests in Renal Cell Carcinoma

By ASCO Genitourinary Cancers Symposium FEATURING Michael Dean
By ASCO Genitourinary Cancers Symposium FEATURING Michael Dean
176 views
February 26, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

21:17
Janssen Oncology

The Man Cave

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Related Content

AUTOPLAY
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
13:37
SIR 2023 Conference Coverage

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary
15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
07:10
Viktor Grünwald

Updated Results From the CLEAR Trial: Outcomes of the Combination of…

16:19
OncoAlert

Year in Review: RCC Practice Changing and Practice Informing Trials …

Feat. T. Choueiri
09:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab f…

Feat. B. McGregor
15:17
ASCO GU 2023 Conference Coverage

ASCO GU 2023 Systemic Therapy for Recurrent Metastatic RCC: Beyond S…

Feat. T. Zhang
15:44
Matthew Campbell

How to Select Frontline Therapy for Metastatic Clear Cell RCC

09:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "State-of-the-Art in Adjuvant Treatment of …

Feat. G. de Velasco
23:16
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients…

Feat. B. McGregor
09:54
Insights from 2024 ASCO® GU Annual Meeting

The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors

Feat. R. McKay
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

09:03
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Long-Term Follow-Up Data From the Chec…

Feat. D. McDermott
15:50
Pavlos Msaouel

First-Line Treatment Options in Advanced RCC: How to Choose

19:42
International Urology Cancer Summit - IUCS

How to Choose 1L Therapy for mRCC

Feat. M. Pal
52:18
The France Foundation

Immune Checkpoint Inhibitors & RCC: Where Are We Now?

Feat. P. Barata, T. Zhang, K. Virdee
22:03
Dana-Farber Cancer Institute

RCC Highlights From ASCO® GU 2024

Feat. W. Xu, T. Choueiri